These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 12812260)

  • 21. Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease.
    Emanuele E; Peros E; Tomaino C; Feudatari E; Bernardi L; Binetti G; Maletta R; D'Angelo A; Montagna L; Bruni AC; Geroldi D
    Neurosci Lett; 2004 Feb; 357(1):45-8. PubMed ID: 15036610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients.
    Wanner C; Bartens W; Walz G; Nauck M; Schollmeyer P
    Nephrol Dial Transplant; 1995; 10(1):75-81. PubMed ID: 7724034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relation of pentanucleotide repeat polymorphism of apolipoprotein (a) gene to plasma lipoprotein (a) level among Chinese patients with myocardial infarction and cerebral infarction].
    Liu X; Sun L; Li Z; Gao Y; Hui R
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1396-400. PubMed ID: 12509922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian women.
    Derosa G; Fogari R; Piccinni MN; Peros E; Bertone G; Ciccarelli L; Tinelli C; Geroldi D; Pannacciulli N; De Pergola G
    Obes Res; 2004 Aug; 12(8):1322-6. PubMed ID: 15340115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chimpanzee lipoprotein(A): Relationship between apolipoprotein(A) isoform size and the density profile of lipoprotein(A) in animals with different heterozygous apo(A) phenotypes.
    Doucet C; Wickings J; Chapman J; Thillet J
    J Med Primatol; 1998 Feb; 27(1):21-7. PubMed ID: 9606039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production.
    Rader DJ; Cain W; Zech LA; Usher D; Brewer HB
    J Clin Invest; 1993 Feb; 91(2):443-7. PubMed ID: 8432853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interrelationship of triglyceride-rich lipoproteins, serum lipoprotein (a) concentration and apolipoprotein(a) size.
    Sentí M; Pedro-Botet J; Rubiés-Prat J; Marrugat J
    Scand J Clin Lab Invest; 1996 Jul; 56(4):311-8. PubMed ID: 8837237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
    Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
    J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.
    Kang C; Dominguez M; Loyau S; Miyata T; Durlach V; Anglés-Cano E
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1232-8. PubMed ID: 12117743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein(a) size polymorphism in young adults with ischemic stroke.
    Peynet J; Beaudeux JL; Woimant F; Flourié F; Giraudeaux V; Vicaut E; Launay JM
    Atherosclerosis; 1999 Jan; 142(1):233-9. PubMed ID: 9920527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.
    Kollerits B; Drechsler C; Krane V; Lamina C; März W; Dieplinger H; Ritz E; Wanner C; Kronenberg F;
    Nephrol Dial Transplant; 2016 Nov; 31(11):1901-1908. PubMed ID: 26754832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma Lp(a), apolipoprotein(a) isoforms and acute myocardial infarction in men and women: a case-control study in the Jerusalem population.
    Kark JD; Sandholzer C; Friedlander Y; Utermann G
    Atherosclerosis; 1993 Jan; 98(2):139-51. PubMed ID: 8457257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The identification of polymorphisms in the coding region of the apolipoprotein (a) gene--association with earlier identified polymorphic sites and influence on the lipoprotein (a) concentration.
    Prins J; Leus FR; Bouma BN; van Rijn HJ
    Thromb Haemost; 1999 Dec; 82(6):1709-17. PubMed ID: 10613659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LPA gene: interaction between the apolipoprotein(a) size ('kringle IV' repeat) polymorphism and a pentanucleotide repeat polymorphism influences Lp(a) lipoprotein level.
    Røsby O; Berg K
    J Intern Med; 2000 Jan; 247(1):139-52. PubMed ID: 10672142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Polynesian-specific SLC22A3 variant associates with low plasma lipoprotein(a) concentrations independent of apo(a) isoform size in males.
    Wang Q; McCormick S; Leask MP; Watson H; O'Sullivan C; Krebs JD; Hall R; Whitfield P; Merry TL; Murphy R; Shepherd PR
    Biosci Rep; 2024 Jul; 44(7):. PubMed ID: 38896441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension.
    Gazzaruso C; Buscaglia P; Garzaniti A; Falcone C; Mariotti S; Savino S; Bonetti G; Finardi G; Geroldi D
    J Hypertens; 1997 Mar; 15(3):227-35. PubMed ID: 9468449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of apolipoprotein(a) size to alzheimer's disease and vascular dementia.
    Emanuele E; Peros E; Tomaino C; Feudatari E; Bernardi L; Binetti G; Maletta R; Micieli G; Bruni AC; Geroldi D
    Dement Geriatr Cogn Disord; 2004; 18(2):189-96. PubMed ID: 15211075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization.
    Roeseler E; Julius U; Heigl F; Spitthoever R; Heutling D; Breitenberger P; Leebmann J; Lehmacher W; Kamstrup PR; Nordestgaard BG; Maerz W; Noureen A; Schmidt K; Kronenberg F; Heibges A; Klingel R;
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2019-27. PubMed ID: 27417585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms in human apolipoprotein(a) kringle IV-10 and coronary artery disease: relationship to allele size, plasma lipoprotein(a) concentration, and lysine binding site activity.
    Simó JM; Joven J; Vilella E; Ribas M; Figuera L; Virgos C; Sundaram IM; Hoover-Plow J
    J Mol Med (Berl); 2001 Jun; 79(5-6):294-9. PubMed ID: 11485023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease.
    Martín S; Pedro-Botet J; Joven J; Simó JM; Ladona MG; Pavesi M; Rubiés-Prat J
    J Lab Clin Med; 2002 Mar; 139(3):181-7. PubMed ID: 11944029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.